MARSHALL WACE, LLP - NPS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$249,000
-41.0%
6,954
-57.1%
0.00%
-50.0%
Q3 2014$422,000
-80.5%
16,215
-75.2%
0.01%
-81.2%
Q2 2014$2,161,000
+356.9%
65,372
+314.0%
0.03%
+255.6%
Q1 2014$473,000–15,792–0.01%–
 Download
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders